Published in Diabetologia on December 01, 1997
Cardiovascular Variability Analysis and Baroreflex Estimation in Patients with Type 2 Diabetes in Absence of Any Manifest Neuropathy. PLoS One (2016) 1.40
Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol (2012) 1.36
Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes (2014) 1.19
Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care (2013) 1.16
Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res (2001) 1.04
Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction. Hypertension (2014) 1.04
Association between cardiovascular autonomic neuropathy and left ventricular dysfunction: DCCT/EDIC study (Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications). J Am Coll Cardiol (2012) 1.00
Decreased heart rate variability may predict the progression of carotid atherosclerosis in type 2 diabetes. Clin Auton Res (2006) 0.98
Resting heart rate and the risk of microvascular complications in patients with type 2 diabetes mellitus. J Am Heart Assoc (2012) 0.92
Blood pressure regulation in diabetic patients with and without peripheral neuropathy. Am J Physiol Regul Integr Comp Physiol (2011) 0.92
Abnormal autonomic cardiovascular control in ankylosing spondylitis. Ann Rheum Dis (1999) 0.92
Hemodynamic and autonomic response to acute hemorrhage in streptozotocin-induced diabetic rats. Cardiovasc Diabetol (2010) 0.90
Cardiac autonomic function correlates with arterial stiffness in the early stage of type 1 diabetes. Exp Diabetes Res (2011) 0.89
Should 24-h ambulatory blood pressure monitoring be done in every patient with diabetes? Diabetes Care (2009) 0.88
Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction. Exp Physiol (2012) 0.86
Angiotensin II-NADPH oxidase-derived superoxide mediates diabetes-attenuated cell excitability of aortic baroreceptor neurons. Am J Physiol Cell Physiol (2011) 0.81
Autonomic control during acute hypoglycemia in type 1 diabetes mellitus. Clin Auton Res (2014) 0.80
Should white-coat hypertension in diabetes be treated? Pro. Diabetes Care (2009) 0.80
Elevated angiotensin II in rat nodose ganglia primes diabetes-blunted arterial baroreflex sensitivity: involvement of NADPH oxidase-derived superoxide. J Diabetes Metab (2011) 0.79
Interoception and stress. Front Psychol (2015) 0.79
Development of a new method for assessing the cardiac baroreflex: response to downward tilting in patients with diabetes mellitus. Heart (2001) 0.78
Association between Brachial-Ankle pulse wave velocity and cardiac autonomic neuropathy in type 2 diabetes. Diabetol Metab Syndr (2014) 0.78
Heart Rate Dynamics after Exercise in Cardiac Patients with and without Type 2 Diabetes. Front Physiol (2011) 0.78
New squatting test indices are useful for assessing baroreflex sensitivity in diabetes mellitus. Diabet Med (2008) 0.78
Baroreflex sensitivity and its response to deep breathing predict increase in blood pressure in type 1 diabetes in a 5-year follow-up. Diabetes Care (2011) 0.78
Effect of hypoxia on heart rate variability and baroreflex sensitivity during hypoglycemia in type 1 diabetes mellitus. Clin Auton Res (2015) 0.77
Mild obstructive sleep apnea does not modulate baroreflex sensitivity in adult patients. Nat Sci Sleep (2015) 0.77
Role of hyperglycaemia in the pathogenesis of hypotension observed in type-1 diabetic rats. Int J Exp Pathol (2008) 0.77
High-pass filter characteristics of the baroreflex--a comparison of frequency domain and pharmacological methods. PLoS One (2013) 0.77
Daytime baroreflex sensitivity in patients with primary insomnia. Clin Res Cardiol (2010) 0.76
Arterial baroreflex control of sympathetic nerve activity and heart rate in patients with type 2 diabetes. Am J Physiol Heart Circ Physiol (2016) 0.76
Evaluation of the indications and arrhythmic patterns of 24 hour Holter electrocardiography among hypertensive and diabetic patients seen at OAUTHC, Ile-Ife Nigeria. Diabetes Metab Syndr Obes (2014) 0.76
Rosiglitazone increases cerebral klotho expression to reverse baroreflex in type 1-like diabetic rats. Biomed Res Int (2014) 0.76
Sympathetic activity and early mobilization in patients in intensive and intermediate care with severe brain injuries: a preliminary prospective randomized study. BMC Neurol (2016) 0.75
Arg16Gly and Gln27Glu β2 adrenergic polymorphisms influence cardiac autonomic modulation and baroreflex sensitivity in healthy young Brazilians. Am J Transl Res (2015) 0.75
Associations of baroreflex sensitivity, heart rate variability, and initial orthostatic hypotension with prenatal and recent postnatal methylmercury exposure in the Seychelles Child Development Study at age 19 years. Int J Environ Res Public Health (2015) 0.75
Effect of One-Week Salt Restriction on Blood Pressure Variability in Hypertensive Patients with Type 2 Diabetes. PLoS One (2016) 0.75
Short-term aerobic exercise reduces nitroglycerin-induced orthostatic intolerance in older adults with type 2 diabetes. J Cardiovasc Pharmacol (2011) 0.75
The Neural Baroreflex Pathway in Subjects With Metabolic Syndrome: A Sub-Study of the Paris Prospective Study III. Medicine (Baltimore) (2016) 0.75
Can coefficient of variation of time-domain analysis be valuable for detecting cardiovascular autonomic neuropathy in young patients with type 1 diabetes: a case control study. BMC Cardiovasc Disord (2017) 0.75
Arterial baroreflex dysfunction in major depressive disorder. Clin Auton Res (2010) 0.75
Cross-spectral analysis of cardiovascular variables in supine diabetic patients. Clin Auton Res (2005) 0.75
Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ (2001) 4.66
An algorithm for finding signals of unknown length in DNA sequences. Bioinformatics (2001) 3.71
Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis (1998) 3.50
Comparison of finger and intra-arterial blood pressure monitoring at rest and during laboratory testing. Hypertension (1989) 3.13
1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens (1999) 2.72
Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens (1987) 2.21
Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet (1983) 2.18
Arterial stiffness. J Hypertens (1999) 2.16
Baroreflex effectiveness index: an additional measure of baroreflex control of heart rate in daily life. Am J Physiol Regul Integr Comp Physiol (2001) 2.09
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study). Circulation (2001) 2.08
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
Spectral analysis of blood pressure and heart rate variability in evaluating cardiovascular regulation. A critical appraisal. Hypertension (1995) 2.04
The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03
How to measure baroreflex sensitivity: from the cardiovascular laboratory to daily life. J Hypertens (2000) 2.02
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Prognostic value of 24-hour blood pressure variability. J Hypertens (1993) 1.84
Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens (1998) 1.80
Alerting reaction and rise in blood pressure during measurement by physician and nurse. Hypertension (1987) 1.80
Sympathetic activation in obese normotensive subjects. Hypertension (1995) 1.78
A new approach to analysis of the arterial baroreflex. J Hypertens Suppl (1985) 1.76
Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res (1983) 1.74
Seasonal variations in home and ambulatory blood pressure in the PAMELA population. Pressione Arteriose Monitorate E Loro Associazioni. J Hypertens (1998) 1.73
Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension (1988) 1.69
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia (2005) 1.69
Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol (1988) 1.64
Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation (1998) 1.60
Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension (1998) 1.58
Management of obstructive sleep apnea in Europe. Sleep Med (2010) 1.56
Sympathoadrenergic and metabolic factors are involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens (2007) 1.55
Broad-band spectral analysis of 24 h continuous finger blood pressure: comparison with intra-arterial recordings. Clin Sci (Lond) (1999) 1.52
Dissociation between muscle and skin sympathetic nerve activity in essential hypertension, obesity, and congestive heart failure. Hypertension (1998) 1.51
Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46
Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation (1994) 1.45
Potassium depletion and salt sensitivity in essential hypertension. J Clin Endocrinol Metab (2001) 1.44
Early 24-hour blood pressure elevation in normotensive subjects with parental hypertension. Hypertension (1990) 1.43
Cardiovascular effects of an earthquake: direct evidence by ambulatory blood pressure monitoring. Hypertension (2001) 1.43
Radial artery wall alterations in genetic hemochromatosis before and after iron depletion therapy. Hepatology (2000) 1.42
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology (1997) 1.41
Metabolic syndrome and biventricular hypertrophy in essential hypertension. J Hum Hypertens (2008) 1.39
Lack of autonomic contributions to tonic nitric oxide-mediated vasodilatation in unanesthetized free-moving rats. J Hypertens (1998) 1.39
Atrial natriuretic factor and arterial baroreceptor reflexes in unanesthetized rats. Hypertension (1990) 1.37
Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens (2001) 1.36
Spectral and sequence analysis of finger blood pressure variability. Comparison with analysis of intra-arterial recordings. Hypertension (1993) 1.34
Ambulatory blood pressure monitoring and organ damage. Hypertension (2000) 1.30
Hypothyroidism and polyneuropathy. J Neurol Neurosurg Psychiatry (1989) 1.30
Persistent blood pressure increase induced by heavy smoking. J Hypertens (1992) 1.29
Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension (2000) 1.28
Feasibility of ambulatory, continuous 24-hour finger arterial pressure recording. Hypertension (1993) 1.28
Influence of carotid baroreceptors on vascular responses to carotid chemoreceptor stimulation in the dog. Circ Res (1975) 1.27
Blood Pressure Monitoring. Task force V: White-coat hypertension. Blood Press Monit (1999) 1.26
Heart rate as marker of sympathetic activity. J Hypertens (1998) 1.23
Effects of aging on 24-h dynamic baroreceptor control of heart rate in ambulant subjects. Am J Physiol (1995) 1.23
GeneSyn: a tool for detecting conserved gene order across genomes. Bioinformatics (2004) 1.23
Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies. J Hum Hypertens (2011) 1.23
Interplay among carotid sinus, cardiopulmonary, and carotid body reflexes in dogs. Am J Physiol (1976) 1.22
The variable-pressure neck-chamber method for studying the carotid baroreflex in man. Clin Sci Mol Med (1977) 1.20
Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma. J Immunol (2000) 1.18
Task Force II: blood pressure measurement and cardiovascular outcome. Blood Press Monit (2001) 1.18
Reproducibility of non-invasive and intra-arterial blood pressure monitoring: implications for studies on antihypertensive treatment. J Hypertens (1991) 1.17
Continuous vs intermittent blood pressure measurements in estimating 24-hour average blood pressure. Hypertension (1983) 1.17
Autonomic cardiac regulation in obstructive sleep apnea syndrome: evidence from spontaneous baroreflex analysis during sleep. J Hypertens (1997) 1.16
Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit (1999) 1.13
Effects of chronic ACE inhibition on sympathetic nerve traffic and baroreflex control of circulation in heart failure. Circulation (1997) 1.11
The European Sleep Apnoea Database (ESADA): report from 22 European sleep laboratories. Eur Respir J (2011) 1.11